GoalVest Advisory »

Gyre Therapeutics Incorporated shares owned by GoalVest Advisory

Quarter-by-quarter ownership of Gyre Therapeutics Incorporated (GYRE) shares owned by GoalVest Advisory from 13F filings

Historical chart of GoalVest Advisory investment in Gyre Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Gyre Therapeutics Incorporated held by GoalVest Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gyre Therapeutics Incorporated by GoalVest Advisory

Quarter filed Position value Share count Share price at filing
2026-03-31 $349 50 6.98

More positions owned by GoalVest Advisory

Vanguard S&p 500 Etf Etf (VOO)
Vanguard Growth Etf Etf (VUG)
State Street Spdr Portfolio Intermediate Term Corporate Bond Etf Etf (SPIB)
Goldman Sachs Municipal Income Etf Etf (GMUB)
State Street Spdr Nyse Technology Etf Etf (XNTK)
Ishares Core Msci Eafe Etf Etf (IEFA)
Vanguard Total Stock Market Etf Etf (VTI)
Vanguard Ftse Europe Etf Etf (VGK)
Goldman Sachs Physical Gold Etf Etf (AAAU)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Nvidia Corporation Stock (NVDA)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Microsoft Corp Stock (MSFT)
Spear Alpha Etf Etf (SPRX)
Palantir Technologies Inc Cl A Stock (PLTR)

View all positions for GoalVest Advisory

Top funds holding Gyre Therapeutics Incorporated

Vanguard Group
BlackRock
Geode Capital Management
State Street Corporation
Charles Schwab Investment Management
SBI Securities
Northern Trust
Bank of New York Mellon
Goldman Sachs Group
State of Wisconsin Investment Board
Alliancebernstein
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Barclays
Rhumbline Advisers
Wells Fargo & Company

View all funds holding Gyre Therapeutics Incorporated